Clinical Trials · NCT07216651
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Closed Loop Medicine
- Enrollment
- 20
- Start date
- Sep 2025
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of participants who persisted on semaglutide treatment over the study period